AbbVie plans to expand of one of its existing sites in Barceloneta with an estimated investment of $30 million. The expansion will add to Puerto Rico’s capabilities as a manufacturing destination for biotechnology and is expected to create up to 100 new jobs over the next two years, according to a press release.
“AbbVie’s expansion in Barceloneta is very important for us, as this site is one of the world's most advanced biopharmaceutical facilities, contributing to our island's growing reputation as a biotech hub,” said Puerto Rico governor Alejandro García Padilla.
According to Stephen Muldoon, vice president of engineering and operations for AbbVie, “This investment demonstrates our commitment to Puerto Rico as a key element of our global manufacturing network. Our presence in Puerto Rico dates to 1969 and our patients benefit from our dedicated and talented local team.”
The support of the Puerto Rico Industrial Development Company (PRIDCO) has been instrumental during the consideration of this project. Given its strategic importance to Puerto Rico’s manufacturing capabilities, PRIDCO will promote the expansion with incentives for job creation and infrastructure.